BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8412015)

  • 1. Non-ketotic hyperglycinaemia: molecular lesion, diagnosis and pathophysiology.
    Tada K; Kure S
    J Inherit Metab Dis; 1993; 16(4):691-703. PubMed ID: 8412015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-ketotic hyperglycinemia: a life-threatening disorder in the neonate.
    Tada K; Kure S; Takayanagi M; Kume A; Narisawa K
    Early Hum Dev; 1992; 29(1-3):75-81. PubMed ID: 1396281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of placental enzyme analysis in assessment of the newborn at risk for non-ketotic hyperglycinaemia (NKH).
    Toone JR; Applegarth DA
    J Inherit Metab Dis; 1989; 12(3):281-5. PubMed ID: 2515368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of non-ketotic hyperglycinaemia: a partial deletion of P-protein gene.
    Tada K; Kure S; Kume A; Hiraga K
    J Inherit Metab Dis; 1990; 13(5):766-70. PubMed ID: 2246863
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel mutations in the P-protein (glycine decarboxylase) gene in patients with glycine encephalopathy (non-ketotic hyperglycinemia).
    Toone JR; Applegarth DA; Kure S; Coulter-Mackie MB; Sazegar P; Kojima K; Ichinohe A
    Mol Genet Metab; 2002 Jul; 76(3):243-9. PubMed ID: 12126939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia.
    Kure S; Takayanagi M; Narisawa K; Tada K; Leisti J
    J Clin Invest; 1992 Jul; 90(1):160-4. PubMed ID: 1634607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-ketotic hyperglycinemia].
    Kálmánchey R; Szücs L; Majtényi K; Liptai Z; Dobos M; Krause I; Nagy I
    Orv Hetil; 1995 Jan; 136(5):245-9. PubMed ID: 7772127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems of prenatal diagnosis of non-ketotic hyperglycinaemia.
    von Wendt L; Similä S; Ruokonen A; Hartikainen-Sorri AL
    J Inherit Metab Dis; 1983; 6(3):112-3. PubMed ID: 6422141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ketotic hyperglycinemia: an aim of the second generation of studies on pathogenesis.
    Hiraga K; Koyata H; Sakakibara T; Ishiguro Y; Matsui C
    Mol Biol Med; 1991 Feb; 8(1):65-79. PubMed ID: 1943691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of mutations in the glycine decarboxylase gene in patients with nonketotic hyperglycinaemia.
    Sellner L; Edkins E; Greed L; Lewis B
    Mol Genet Metab; 2005 Feb; 84(2):167-71. PubMed ID: 15670722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and expression of the glycine cleavage system in rat central nervous system.
    Sakata Y; Owada Y; Sato K; Kojima K; Hisanaga K; Shinka T; Suzuki Y; Aoki Y; Satoh J; Kondo H; Matsubara Y; Kure S
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):119-30. PubMed ID: 11597772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonketotic hyperglycinemia: biochemical, molecular, and neurological aspects.
    Kure S; Tada K; Narisawa K
    Jpn J Hum Genet; 1997 Mar; 42(1):13-22. PubMed ID: 9183995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of non-ketotic hyperglycinaemia.
    Toone JR; Applegarth DA; Levy HL
    J Inherit Metab Dis; 1992; 15(5):713-9. PubMed ID: 1434509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and expression analyses of normal and mutant mRNA encoding glycine decarboxylase: three-base deletion in mRNA causes nonketotic hyperglycinemia.
    Kure S; Narisawa K; Tada K
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1176-82. PubMed ID: 1996985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia.
    Kanno J; Hutchin T; Kamada F; Narisawa A; Aoki Y; Matsubara Y; Kure S
    J Med Genet; 2007 Mar; 44(3):e69. PubMed ID: 17361008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of serine medication in non-ketotic hyperglycinaemia due to deficiency of P-protein of the glycine cleavage complex.
    Wijburg FA; de Groot CJ; Schutgens RB; Barth PG; Tada K
    J Inherit Metab Dis; 1988; 11 Suppl 2():218-20. PubMed ID: 3141706
    [No Abstract]   [Full Text] [Related]  

  • 17. One-methyl group metabolism in non-ketotic hyperglycinaemia: mildly elevated cerebrospinal fluid homocysteine levels.
    Van Hove JL; Lazeyras F; Zeisel SH; Bottiglieri T; Hyland K; Charles HC; Gray L; Jaeken J; Kahler SG
    J Inherit Metab Dis; 1998 Dec; 21(8):799-811. PubMed ID: 9870205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impaired expression of glycine decarboxylase in patients with hyperglycinemias.
    Kume A; Kure S; Tada K; Hiraga K
    Biochem Biophys Res Commun; 1988 Jul; 154(1):292-7. PubMed ID: 3395333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal non-ketotic hyperglycinemia (NKH). Diagnoses and management in two cases.
    Holmqvist P; Polberger S
    Neuropediatrics; 1985 Nov; 16(4):191-3. PubMed ID: 4080094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension associated with nonketotic hyperglycinaemia.
    Cataltepe S; van Marter LJ; Kozakewich H; Wessel DL; Lee PJ; Levy HL
    J Inherit Metab Dis; 2000 Mar; 23(2):137-44. PubMed ID: 10801055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.